In term of cardiovascular disease, SENP3 has been shown to be upregulated in atherosclerosis, where it stabilizes β-catenin protein through deSUMOylation, thereby promoting VSMC migration and aggravating atherosclerosis (Cai et al. 2021). Here, SENP3 is linked to cardiovascular disorder.